Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib versus ibuprofen and placebo for pain after total knee replacement surgery
2008-003379-28Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of etoricoxib and ibuprofen in postoperative pain (4 arms), sponsored by Merck & Co. Primary endpoints: Average pain intensity difference at rest over Days 1 through 3 versus placebo and Total daily morphine dose over Days 1 through 3. Started Jan 2009; status: completed.
02
Drugs
etoricoxibibuprofen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2008-003379-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003379-28.